Bank of Montreal’s Sunshine Biopharma SBFM Stock Holding History

Bank of Montreal’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2	Closed	-$28.2K	–	4255
2023 Q1	$28.2K	Hold	2	–	–	﹤0.01%	3469
2022 Q4	$21.6K	Hold	2	–	–	﹤0.01%	3683
2022 Q3	$33	Hold	2	–	–	﹤0.01%	3720
2022 Q2	$40	Buy	+2	New	+$97.7K	﹤0.01%	3670

Other funds holding SBFM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

NECFA

New England Capital Financial Advisors Meriden, Connecticut $418M AUM 16.7% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's SBFM Position: Q2 2023 in Review

Bank of Montreal sold out of Sunshine Biopharma (SBFM) in Q2 2023, closing a stake of 2 shares — an estimated $28.2K sold.

Bank of Montreal first reported a position in SBFM in Q2 2022 and held it in 4 quarters. The position peaked at $28.2K in Q1 2023. 4 funds tracked by Wall St. Rank hold SBFM as of Q2 2023.

Bank of Montreal reported no remaining Sunshine Biopharma position as of Q2 2023 after selling out during the quarter.
Bank of Montreal sold 2 Sunshine Biopharma shares in Q2 2023, an estimated $28.2K.
Bank of Montreal first reported a position in Sunshine Biopharma in Q2 2022 and held it in 4 quarters.
Bank of Montreal's Sunshine Biopharma position peaked at $28.2K in Q1 2023.
4 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.